{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:02:48Z","timestamp":1792188168729,"version":"4.4.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2014,8,17]],"date-time":"2014-08-17T00:00:00Z","timestamp":1408233600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s00467-014-2913-5","type":"journal-article","created":{"date-parts":[[2014,8,16]],"date-time":"2014-08-16T07:17:28Z","timestamp":1408173448000},"page":"2411-2414","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Serum suPAR levels are modulated by immunosuppressive therapy of minimal change nephrotic syndrome"],"prefix":"10.1007","volume":"29","author":[{"given":"Jutta","family":"Gellermann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Querfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,17]]},"reference":[{"key":"2913_CR1","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm.2411","volume":"17","author":"C Wei","year":"2011","unstructured":"Wei C, El Hindi S, Li J, Fornoni A, Goes N, Sageshima J, Maiguel D, Karumanchi SA, Yap HK, Saleem M, Zhang Q, Nikolic B, Chaudhuri A, Daftarian P, Salido E, Torres A, Salifu M, Sarwal MM, Schaefer F, Morath C, Schwenger V, Zeier M, Gupta V, Roth D, Rastaldi MP, Burke G, Ruiz P, Reiser J (2011) Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 17:952\u2013960","journal-title":"Nat Med"},{"key":"2913_CR2","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1681\/ASN.2012030302","volume":"23","author":"C Wei","year":"2012","unstructured":"Wei C, Trachtman H, Li J, Dong C, Friedman AL, Gassman JJ, McMahan JL, Radeva M, Heil KM, Trautmann A, Anarat A, Emre S, Ghiggeri GM, Ozaltin F, Haffner D, Gipson DS, Kaskel F, Fischer DC, Schaefer F, Reiser J (2012) Circulating suPAR in two cohorts of primary FSGS. J Am Soc Nephrol 23:2051\u20132059","journal-title":"J Am Soc Nephrol"},{"key":"2913_CR3","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/ki.2013.55","volume":"84","author":"J Huang","year":"2013","unstructured":"Huang J, Liu G, Zhang YM, Cui Z, Wang F, Liu XJ, Chu R, Chen Y, Zhao MH (2013) Plasma soluble urokinase receptor levels are increased but do not distinguish primary from secondary focal segmental glomerulosclerosis. Kidney Int 84:366\u2013372","journal-title":"Kidney Int"},{"key":"2913_CR4","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.2215\/CJN.07680712","volume":"8","author":"ME Bock","year":"2013","unstructured":"Bock ME, Price HE, Gallon L, Langman CB (2013) Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: A single-center report. Clin J Am Soc Nephrol 8:1304\u20131311","journal-title":"Clin J Am Soc Nephrol"},{"key":"2913_CR5","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/ki.2013.544","volume":"85","author":"T Wada","year":"2014","unstructured":"Wada T, Nangaku M, Maruyama S, Imai E, Shoji K, Kato S, Endo T, Muso E, Kamata K, Yokoyama H, Fujimoto K, Obata Y, Nishino T, Kato H, Uchida S, Sasatomi Y, Saito T, Matsuo S (2014) A multicenter cross-sectional study of circulating soluble urokinase receptor in Japanese patients with glomerular disease. Kidney Int 85:641\u2013648","journal-title":"Kidney Int"},{"key":"2913_CR6","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/ki.2013.505","volume":"85","author":"B Meijers","year":"2014","unstructured":"Meijers B, Maas RJ, Sprangers B, Claes K, Poesen R, Bammens B, Naesens M, Deegens JK, Dietrich R, Storr M, Wetzels JF, Evenepoel P, Kuypers D (2014) The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis. Kidney Int 85:636\u2013640","journal-title":"Kidney Int"},{"key":"2913_CR7","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/ki.2013.546","volume":"85","author":"A Sinha","year":"2014","unstructured":"Sinha A, Bajpai J, Saini S, Bhatia D, Gupta A, Puraswani M, Dinda AK, Agarwal SK, Sopory S, Pandey RM, Hari P, Bagga A (2014) Serum-soluble urokinase receptor levels do not distinguish focal segmental glomerulosclerosis from other causes of nephrotic syndrome in children. Kidney Int 85:649\u2013658","journal-title":"Kidney Int"},{"key":"2913_CR8","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.2215\/CJN.06170613","volume":"8","author":"S Sever","year":"2013","unstructured":"Sever S, Trachtman H, Wei C, Reiser J (2013) Is there clinical value in measuring suPAR Levels in FSGS? Clin J Am Soc Nephrol 8:1273\u20131275","journal-title":"Clin J Am Soc Nephrol"},{"key":"2913_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10753-009-9152-0","volume":"33","author":"BK Pliyev","year":"2010","unstructured":"Pliyev BK, Menshikov MY (2010) Release of the soluble urokinase-type plasminogen activator receptor (suPAR) by activated neutrophils in rheumatoid arthritis. Inflammation 33:1\u20139","journal-title":"Inflammation"},{"key":"2913_CR10","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.2215\/CJN.01520209","volume":"4","author":"S Kengne-Wafo","year":"2009","unstructured":"Kengne-Wafo S, Massella L, Diomedi-Camassei F, Gianviti A, Vivarelli M, Greco M, Stringini GR, Emma F (2009) Risk factors for cyclosporin A nephrotoxicity in children with steroid-dependant nephrotic syndrome. Clin J Am Soc Nephrol 4:1409\u20131416","journal-title":"Clin J Am Soc Nephrol"},{"key":"2913_CR11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00467-003-1300-4","volume":"19","author":"J Gellermann","year":"2004","unstructured":"Gellermann J, Querfeld U (2004) Frequently relapsing nephrotic syndrome: treatment with mycophenolate mofetil. Pediatr Nephrol 19:101\u2013104","journal-title":"Pediatr Nephrol"},{"key":"2913_CR12","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/ki.2012.32","volume":"81","author":"RJ Maas","year":"2012","unstructured":"Maas RJ, Wetzels JF, Deegens JK (2012) Serum-soluble urokinase receptor concentration in primary FSGS. Kidney Int 81:1043\u20131044","journal-title":"Kidney Int"},{"key":"2913_CR13","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1681\/ASN.2012121200","volume":"24","author":"J Gellermann","year":"2013","unstructured":"Gellermann J, Weber L, Pape L, Tonshoff B, Hoyer P, Querfeld U (2013) Mycophenolate mofetil versus cyclosporin A in children with frequently relapsing nephrotic syndrome. J Am Soc Nephrol 24:1689\u20131697","journal-title":"J Am Soc Nephrol"},{"key":"2913_CR14","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.trsl.2012.04.004","volume":"160","author":"K Pawlak","year":"2012","unstructured":"Pawlak K, Ulazka B, Mysliwiec M, Pawlak D (2012) Vascular endothelial growth factor and uPA\/suPAR system in early and advanced chronic kidney disease patients: a new link between angiogenesis and hyperfibrinolysis? Transl Res 160:346\u2013354","journal-title":"Transl Res"},{"key":"2913_CR15","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00109-012-0960-6","volume":"90","author":"B Zhang","year":"2012","unstructured":"Zhang B, Shi W, Ma J, Sloan A, Faul C, Wei C, Reiser J, Yang Y, Liu S, Wang W (2012) The calcineurin-NFAT pathway allows for urokinase receptor-mediated beta3 integrin signaling to cause podocyte injury. J Mol Med (Berl) 90:1407\u20131420","journal-title":"J Mol Med (Berl)"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-014-2913-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-014-2913-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-014-2913-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T21:07:04Z","timestamp":1559077624000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-014-2913-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,17]]},"references-count":15,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2913"],"URL":"https:\/\/doi.org\/10.1007\/s00467-014-2913-5","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,17]]}}}